Cardiovascular Blind Spots and How Cleerly Is Changing the Game
In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...
The hires come in the wake of completing a $43 million series B round of funding this summer.
Featured on Medical Marketing and Media by MM+M Staff
Cleerly, a company attempting to create a higher standard of care for heart disease, has tapped Brandon Atkinson as COO and Nick Nieslanik as CTO. The hires come weeks after Cleerly closed a $43 million series B round of funding this summer. Atkinson previously served as CEO of 46 Summits Consulting, while Nieslanik was formerly VP of engineering at Teladoc Health.
Read the full article HERE.
In The Future of Medicine Podcast, Aaron Wenzel, MD, and Jennifer Justus, MSN, APRN, FNP-C dive into how Cleerly has revolutionized their ability to...
Inside Precision Medicine features our Chief Scientific Officer, Dr. Udo Hoffmann, on how AI has changed CT imaging and the TRANSFORM trial that may...
Selected from more than 10,000 private healthcare companies, Cleerly is named one of CB Insight’s Digital Health 50 based on R&D, Mosaic scores,...
CNBC interviews Cleerly CEO, James Min, MD, on how Cleerly aims to improve personalized cardiac care and create a world without heart attacks. Read...
In this interview, Cleerly Founder and CEO, James Min, MD, shares how despite advances in cardiology, most heart attacks occur without warning....
To reduce heart attack rates, make CCTA the new standard of care.